spacer
home > pmps > spring 2018 > air purity
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Air Purity

As the UK’s pharmaceutical sector continues to grow, so too does the demand for large volumes of highquality compressed air for powering manufacturing processes. Air purity is essential when meeting strict hygiene regulations, designed to prevent process and product contamination. Oil-free technologies can be instrumental in delivering the required air purity, and oil-free compressors can even help deliver improved efficiencies for factory owners and operators.

Often referred to as the ‘fourth utility’, compressed air is pivotal to the pharma manufacturing industry. A reliable supply of compressed air is absolutely vital to a wide variety of applications across the pharma sector. However, because this compressed air comes into direct contact with pharmaceutical products during the manufacturing process, it is of paramount importance that it is of exceptionally high quality.

Even the smallest risk of contamination can have a serious effect on tools such as air curtains, control valves, and cylinders, as well as material handling, process air, and product drying. Such consequences can often only be resolved at significant expense, saddling pharma factory owners and operators with unnecessary costs that could impact their bottom line.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Richard Hilton is the Product Director for Gardner Denver, which delivers a broad range of compressor and vacuum products in a wide array of technologies to end-user and original equipment manufacturer customers to varied sectors worldwide. He is a 28-year veteran of the compressed air industry and has worked across Gardner Denver’s brand portfolio for almost 20 years. Richard is currently responsible for the group’s industrial compressor product groups across Europe, the Middle East, and Asia.
spacer
Richard Hilton
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for pharmaceutical and medical device applications

Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement